DK0807431T3 - Fremgangsmåde til fremstilling af carotenoidpræparater - Google Patents

Fremgangsmåde til fremstilling af carotenoidpræparater

Info

Publication number
DK0807431T3
DK0807431T3 DK97106957T DK97106957T DK0807431T3 DK 0807431 T3 DK0807431 T3 DK 0807431T3 DK 97106957 T DK97106957 T DK 97106957T DK 97106957 T DK97106957 T DK 97106957T DK 0807431 T3 DK0807431 T3 DK 0807431T3
Authority
DK
Denmark
Prior art keywords
carotenoid
preparation
carotenoid preparations
disclosed
emulsion
Prior art date
Application number
DK97106957T
Other languages
Danish (da)
English (en)
Inventor
Leonard Joseph Scialpi
Ray Edward Kowalski
William Joseph Mergens
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of DK0807431T3 publication Critical patent/DK0807431T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/924—Significant dispersive or manipulative operation or step in making or stabilizing colloid system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK97106957T 1996-05-14 1997-04-26 Fremgangsmåde til fremstilling af carotenoidpræparater DK0807431T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1756896P 1996-05-14 1996-05-14

Publications (1)

Publication Number Publication Date
DK0807431T3 true DK0807431T3 (da) 2004-07-26

Family

ID=21783319

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97106957T DK0807431T3 (da) 1996-05-14 1997-04-26 Fremgangsmåde til fremstilling af carotenoidpræparater

Country Status (10)

Country Link
US (1) US6093348A (instruction)
EP (1) EP0807431B1 (instruction)
JP (1) JP3961070B2 (instruction)
CN (1) CN1079212C (instruction)
AT (1) ATE262316T1 (instruction)
BR (1) BR9703134A (instruction)
DE (1) DE69728206T2 (instruction)
DK (1) DK0807431T3 (instruction)
ES (1) ES2216079T3 (instruction)
IN (1) IN183685B (instruction)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT876109E (pt) * 1996-01-22 2003-12-31 Chr Hansen As Composicoes dispersaveis em agua com um pigmento natural hidrofobico as suas tecnicas de preparacao e de utilizacao
AU767154B2 (en) 1998-11-20 2003-10-30 Skyepharma Canada Inc. Dispersible phospholipid stabilized microparticles
AU5711501A (en) * 2000-04-20 2001-11-07 Rtp Pharma Inc Improved water-insoluble drug particle process
US20030104090A1 (en) * 2000-05-05 2003-06-05 Levy Pedro E. Supplements containing annatto extracts and carotenoids and methods for using the same
WO2002024169A1 (en) * 2000-09-20 2002-03-28 Skyepharma Canada Inc. Spray drying process and compositions of fenofibrate
DE10064387A1 (de) * 2000-12-21 2002-06-27 Basf Ag Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Sauerstoff-haltiger Carotinoide
WO2002077105A1 (fr) * 2001-03-22 2002-10-03 Fuji Chemical Industry Co., Ltd. Compositions pulverulentes a base d'astaxanthine et procede de production associe
US6811801B2 (en) * 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
WO2004002453A1 (en) 2002-06-28 2004-01-08 Protiva Biotherapeutics Ltd. Method and apparatus for producing liposomes
US20050049248A1 (en) * 2002-07-29 2005-03-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
US7345091B2 (en) * 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US7723327B2 (en) 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US7320997B2 (en) * 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US20050004235A1 (en) * 2002-07-29 2005-01-06 Lockwood Samuel Fournier Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
US20050026874A1 (en) * 2002-07-29 2005-02-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
US7763649B2 (en) 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
CN101845009B (zh) 2002-07-29 2012-10-03 卡达克斯药物公司 用于抑制和改善疾病的类胡萝卜素结构类似物
US20050059659A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid analogs or derivatives for controlling C-reactive protein levels
JP4773337B2 (ja) * 2003-03-27 2011-09-14 ディーエスエム アイピー アセッツ ビー．ブイ． ビーズレットの製造方法
US7110827B2 (en) * 2003-04-25 2006-09-19 Medtronic, Inc. Electrical connectors for medical lead having weld-less wiring connection
US7332178B2 (en) 2003-04-25 2008-02-19 Abbott Laboratories Stable nutritional powder containing ascorbyl palmitate
US9247765B2 (en) 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
CA2564066A1 (en) * 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
JP4562174B2 (ja) * 2004-08-23 2010-10-13 カゴメ株式会社 カロテノイド含有物の製造方法
AU2005279201B2 (en) * 2004-08-31 2011-08-04 Akzo Nobel N.V. Method for pigment solubilisation, a pigment composition and its use
US10463061B2 (en) * 2004-11-19 2019-11-05 Dsm Ip Assets B.V. Modified plant gums for preparations of active ingredients
US8755258B2 (en) 2005-02-16 2014-06-17 Mitsubishi Electric Corporation Optical disc and optical disc device
CN100421650C (zh) * 2005-03-23 2008-10-01 浙江新和成股份有限公司 水分散性类胡萝卜素粉的制备方法
JP5639338B2 (ja) * 2005-07-27 2014-12-10 プロチバ バイオセラピューティクス インコーポレイティッド リポソームの製造システムおよび製造方法
ES2420155T3 (es) * 2005-08-15 2013-08-22 Phares Drug Delivery Ag Formas de cristal de astaxantina
US7435846B2 (en) 2006-08-18 2008-10-14 Industrial Organica, S.A. De C.V. Absorption and bioavailability of carotenoids, formulations and applications
EA022628B1 (ru) * 2007-03-15 2016-02-29 ДСМ АйПи АССЕТС Б.В. Способ получения суспензии частиц натамицина
WO2009093595A1 (ja) * 2008-01-25 2009-07-30 Fujifilm Corporation カロテノイド含有エマルション組成物の製造方法、それにより得られるカロテノイド含有エマルション組成物並びにカロテノイド含有粉末組成物、該組成物を含む機能性食品及び化粧品
EP2210593A3 (en) 2009-01-21 2011-05-18 DSM IP Assets B.V. Tablettable formulations of vitamin A and derivatives thereof
WO2010111132A2 (en) 2009-03-27 2010-09-30 Bend Research, Inc. Spray-drying process
KR101372757B1 (ko) 2009-09-14 2014-03-10 닛뽕소다 가부시키가이샤 항식물 바이러스제
ES2718845T3 (es) 2010-06-08 2019-07-04 San Ei Gen Ffi Inc Procedimiento para evitar la adhesión de un pigmento carotenoide a un recipiente
JP5600513B2 (ja) * 2010-07-29 2014-10-01 理研ビタミン株式会社 クロセチン製剤の製造方法
PT2611529T (pt) 2010-09-03 2019-05-09 Bend Res Inc Método de secagem por pulverização
EP2611530B1 (en) 2010-09-03 2019-01-16 Bend Research, Inc. Spray-drying apparatus and methods of using the same
US9248584B2 (en) 2010-09-24 2016-02-02 Bend Research, Inc. High-temperature spray drying process and apparatus
CN103327827B (zh) * 2010-11-26 2016-02-10 帝斯曼知识产权资产管理有限公司 用于活性成分的保护性水胶体
US20120157547A1 (en) 2010-12-21 2012-06-21 Ricardo Montoya-Olvera Compositions and applications of carotenoids of improved absorption and bioavailability
CN104736229B (zh) * 2012-10-18 2017-05-03 帝斯曼知识产权资产管理有限公司 包含类胡萝卜素的珠粒
WO2015044222A1 (en) * 2013-09-24 2015-04-02 Dsm Ip Assets B.V. Stable formulations for coloring beverages and food products
PT3212169T (pt) 2014-10-31 2021-05-06 Bend Res Inc Processo para formar domínios ativos dispersos numa matriz
BR112018068553B1 (pt) * 2016-03-15 2022-12-13 Dsm Ip Assets B.V Uso de partículas secas de cor vermelho-laranja e pó para bebida instantânea
JP6954917B2 (ja) * 2016-03-24 2021-10-27 ビーエイエスエフ・ソシエタス・エウロパエアＢａｓｆ Ｓｅ 多相活性物質調製物
KR102411745B1 (ko) * 2016-07-19 2022-06-22 바스프 에스이 프로필 갈레이트-함유 비타민 제형
US11197493B2 (en) * 2017-09-12 2021-12-14 Omniactive Health Technologies Limited Stabilized fat soluble nutrient compositions and process for the preparation thereof
JP7225820B2 (ja) 2019-01-21 2023-02-21 株式会社アイシン 車両用開閉体制御装置
CN114025745A (zh) * 2019-06-17 2022-02-08 帝斯曼知识产权资产管理有限公司 包含盐酸二甲双胍、维生素b12和至少一种流动助剂的组合物
BR112021025180A2 (pt) * 2019-06-17 2022-02-01 Dsm Ip Assets Bv Forma de dosagem farmacêutica sólida compreendendo vitamina b12 seca por pulverização
WO2020254404A1 (en) * 2019-06-17 2020-12-24 Dsm Ip Assets B.V. Pharmaceutical dosage form comprising metformin and calcium citrate
CN112438950A (zh) * 2019-08-16 2021-03-05 北京化工大学 一种β-胡萝卜素透明水分散液及其制备方法
CN111471317B (zh) * 2020-03-26 2021-06-04 广东省农业科学院蚕业与农产品加工研究所 一种稳态化玉米黄色素及其制备方法
CN111838648B (zh) * 2020-06-16 2023-04-25 嘉必优生物技术（武汉）股份有限公司 一种生产纳米级类胡萝卜素乳液的装置及方法
CN116096702A (zh) 2020-07-16 2023-05-09 爱康泰生治疗公司 用于脂质纳米颗粒的阳离子脂质
CN112841645A (zh) * 2021-01-14 2021-05-28 江南大学 一种β-胡萝卜素微胶囊的制备方法
CN113426355A (zh) * 2021-06-25 2021-09-24 骏马化纤股份有限公司 一种化纤生产用油剂乳液自动化控制系统及制备方法
CN118647600A (zh) 2021-12-16 2024-09-13 爱康泰生治疗公司 用于脂质纳米颗粒制剂的脂质
CN118525919A (zh) * 2023-02-22 2024-08-23 浙江可明生物医药有限公司 类胡萝卜素制剂的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756177A (en) * 1953-03-09 1956-07-24 Hoffmann La Roche Process for making fat-soluble vitamin active powder
US2861891A (en) * 1956-12-13 1958-11-25 Hoffmann La Roche Water dispersible carotenoid compositions and process of making the same
DE1211911B (de) * 1959-09-08 1966-03-03 Hoffmann La Roche Verfahren zur Herstellung eines insbesondere zum Faerben von Lebens- und Futtermitteln geeigneten Carotinoidpraeparates
US3998753A (en) * 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
DE3048000A1 (de) * 1980-12-19 1982-07-15 Basf Ag Stabile injizierbare (beta)-carotin-solubilisate und verfahren zu ihrer herstellung
US4908154A (en) * 1981-04-17 1990-03-13 Biotechnology Development Corporation Method of forming a microemulsion
US4533254A (en) * 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
DE3119383A1 (de) * 1981-05-15 1982-12-02 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinodpraeparaten
SE8604117D0 (sv) * 1986-09-29 1986-09-29 Kabivitrum Ab Composition
DE3702031A1 (de) * 1987-01-24 1988-08-04 Basf Ag Verfahren zur herstellung von mikrodispersen fischoelpraeparaten
ATE96312T1 (de) * 1989-07-25 1993-11-15 Hoffmann La Roche Verfahren zur herstellung von carotinoidpraeparaten.
DK546289D0 (da) * 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere
DK19393D0 (da) * 1993-02-19 1993-02-19 Danochemo As Fremgangsmaade til fremstilling af et i vand dispergerbart pulverformigt carotenoidpraeparat
DE4329446A1 (de) * 1993-09-01 1995-03-02 Basf Ag Verfahren zur Herstellung von feinteiligen Farb- oder Wirkstoffzubereitungen
DE19649062A1 (de) * 1996-11-27 1998-05-28 Basf Ag Flüssige, mit Öl mischbare Carotinoid-Zubereitungen

Also Published As

Publication number Publication date
DE69728206D1 (de) 2004-04-29
JP3961070B2 (ja) 2007-08-15
CN1079212C (zh) 2002-02-20
EP0807431B1 (en) 2004-03-24
JPH1046041A (ja) 1998-02-17
EP0807431A3 (en) 1998-08-12
BR9703134A (pt) 1998-08-18
ATE262316T1 (de) 2004-04-15
CN1176760A (zh) 1998-03-25
EP0807431A2 (en) 1997-11-19
US6093348A (en) 2000-07-25
IN183685B (instruction) 2000-03-18
DE69728206T2 (de) 2005-03-10
ES2216079T3 (es) 2004-10-16

Similar Documents

Publication Publication Date Title
DK0807431T3 (da) Fremgangsmåde til fremstilling af carotenoidpræparater
DK0805822T4 (da) Spraytørret erythropoietin
DE69717263D1 (de) Zubereitung mit verzögerter freisetzung und deren herstellung
HU904116D0 (en) Stabilized fgf composition and process for its preparation
AU2741295A (en) Method for preparing an influenza virus, antigens obtained and applications thereof
ES2066491T3 (es) Composiciones de colorantes en polvo y procedimiento para su preparacion.
NO974768D0 (no) Fremgangsmåte for fremstilling av et forbedret lavtstövende, lettflytende pigment
EP0837139A3 (en) Two step conversion of vegetable protein isoflavone conjugates to isoflavone aglucones
AU2808295A (en) Aqueous fluoropolymer emulsion and process for producing the same
EP0755440A4 (en) NOVEL MUT VIRUSES, ANTIVIRAL COMPOUNDS, AND NOVEL VACCINE PRODUCTION METHODS
BR9000736A (pt) Processo para preparar uma composicao aquosa para xampu
FI864703A7 (fi) Veteenliukeneva, lämmössä kovettuva hartsi, menetelmä sen valmistamiseksi paperiliimakoostumus jpaperiliimausmenetelmä.
ES2196743T3 (es) Sorbitol en polvo y su procedimiento de preparacion.
FI972474L (fi) Menetelmä selluloosaeetterin vesisuspension valmistamiseksi sekä kuiva seos, joka sopii käytettäväksi suspension valmistuksessa
DK559887A (da) Fremgangsmaade til fremstilling af carbinolderivater
CA2085114A1 (en) Method for preparation of colored porous polytetrafluorethylene material
DE69503097D1 (de) Veresterungsverfahren eines oligomeren polyphenolischen Extraktes pflanzlicher Herkunft, die so erhaltene Zusammensetzung und ihre Anwendung
PL359625A1 (en) A method of shaping heat-shrinkable materials
HU186343B (en) Pungicide preparations containing 2,3,6-trisubsituted-n-acyl-anilide derivatives as actor as well as method for producing the actors
DE3881326D1 (de) Verfahren zur herstellung von paramunitaetsinducern.
NO963003L (no) Fremgangsmåte for fremstilling av en vandig emulsjon med snever dråpestörrelsesfordeling, og anvendelse av en slik emulsjon for fremstilling av en polymerdispersjon
AU5266790A (en) Hydraulic substance, method of producing and curing the same, curing chamber, and paint
GB8717418D0 (en) Joining of pipes
AU7408591A (en) Plasticizing resins, aqueous dispersions thereof and methods of making the same
ATA251486A (de) Verfahren zur herstellung von neuen loeslichen und/oder schmelzbaren polyamidimid-polyimidblockcopolymeren